A blend whose ingredients have separate preclinical studies in rat brain-ischaemia and stress models.
In simple words
Semax + Selank is a blend of two peptides studied separately in nervous-system research. The selected studies use rat brain-ischaemia and stress models; they do not establish cognitive or mood benefits of the blend in people.
Ingredient studies are shown separately. They do not demonstrate the effects, safety or synergy of the combined vial; exact sequences and unlisted proportions are not assumed.
Male Wistar rats; protein analyses used 5–7 animals per group.
The ACTH-derived analogue altered selected brain proteins associated with inflammation, cell death and recovery after experimentally induced ischaemia.
A rat stroke model does not establish cognitive enhancement or stroke treatment in humans, and did not test the Selank/Semax blend.
PMID 34201112. Open full text checked through Europe PMC on 2026-10-26. Selected evidence, not a systematic review.
Evidence on studied compounds does not establish the identity, purity, safety, or regulatory approval of the catalogue vial. No Canadian regulatory status is assessed here.
Research questions about Semax + Selank
What is Semax + Selank?
Semax + Selank is a blend of two peptides studied separately in nervous-system research. The selected studies use rat brain-ischaemia and stress models; they do not establish cognitive or mood benefits of the blend in people.
What types of research are cited for Semax + Selank?
The Semax + Selank profile contains the following selected evidence on individual ingredients. This is not a systematic review or a complete inventory of research.
Semax in a rat cerebral-ischaemia model (2021): Preclinical — rats
Ingredient studies are shown separately. They do not demonstrate the effects, safety or synergy of the combined vial; exact sequences and unlisted proportions are not assumed.
What do the selected Semax + Selank studies not establish?
Semax in a rat cerebral-ischaemia model (2021): A rat stroke model does not establish cognitive enhancement or stroke treatment in humans, and did not test the Selank/Semax blend.
These studies do not establish the identity, purity, safety or effects of the MXC Semax + Selank vial. Findings in one formulation, population or experimental model should not be assumed to apply to another.